The T‐cell leukaemia/lymphoma 1 (TCL1) oncoprotein has been observed to interact with XBP1 in chronic lymphocytic leukemia (CLL), and the inhibition of XBP1s expression resultes in a reduction in the progression of CLL.259. Here, XBP1 is linked to B-cell chronic lymphocytic leukemia.